Ethic Inc. Sells 5,776 Shares of Kimberly-Clark Corporation $KMB

Ethic Inc. cut its position in shares of Kimberly-Clark Corporation (NASDAQ:KMBFree Report) by 10.9% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 47,325 shares of the company’s stock after selling 5,776 shares during the period. Ethic Inc.’s holdings in Kimberly-Clark were worth $5,884,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in KMB. Empirical Finance LLC increased its stake in shares of Kimberly-Clark by 0.6% during the second quarter. Empirical Finance LLC now owns 11,876 shares of the company’s stock valued at $1,531,000 after buying an additional 76 shares during the period. Mesirow Financial Investment Management Inc. grew its holdings in Kimberly-Clark by 3.7% during the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 2,201 shares of the company’s stock worth $284,000 after acquiring an additional 78 shares in the last quarter. Monarch Capital Management Inc. increased its position in Kimberly-Clark by 1.9% during the 2nd quarter. Monarch Capital Management Inc. now owns 4,372 shares of the company’s stock valued at $568,000 after purchasing an additional 81 shares during the period. TFB Advisors LLC raised its holdings in shares of Kimberly-Clark by 4.2% in the 2nd quarter. TFB Advisors LLC now owns 2,022 shares of the company’s stock valued at $261,000 after purchasing an additional 82 shares in the last quarter. Finally, State of Wyoming raised its holdings in shares of Kimberly-Clark by 3.0% in the 1st quarter. State of Wyoming now owns 2,879 shares of the company’s stock valued at $409,000 after purchasing an additional 85 shares in the last quarter. Institutional investors own 76.29% of the company’s stock.

Kimberly-Clark Stock Performance

Shares of KMB opened at $101.03 on Tuesday. The company has a current ratio of 0.77, a quick ratio of 0.56 and a debt-to-equity ratio of 4.41. The firm has a market cap of $33.53 billion, a PE ratio of 17.09, a P/E/G ratio of 4.39 and a beta of 0.25. Kimberly-Clark Corporation has a 12 month low of $99.22 and a 12 month high of $150.45. The stock has a fifty day moving average price of $106.31 and a 200-day moving average price of $120.34.

Kimberly-Clark (NASDAQ:KMBGet Free Report) last announced its earnings results on Thursday, October 30th. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.45 by $0.37. Kimberly-Clark had a return on equity of 183.11% and a net margin of 10.89%.The firm had revenue of $4.15 billion for the quarter, compared to the consensus estimate of $4.14 billion. During the same period in the previous year, the business earned $1.83 EPS. The firm’s revenue for the quarter was up .1% on a year-over-year basis. Equities research analysts predict that Kimberly-Clark Corporation will post 7.5 earnings per share for the current fiscal year.

Kimberly-Clark Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 5th. Stockholders of record on Friday, December 5th will be issued a dividend of $1.26 per share. The ex-dividend date is Friday, December 5th. This represents a $5.04 annualized dividend and a dividend yield of 5.0%. Kimberly-Clark’s dividend payout ratio is 85.28%.

Analyst Ratings Changes

A number of research firms have recently issued reports on KMB. Morgan Stanley dropped their price objective on shares of Kimberly-Clark from $144.00 to $125.00 and set an “equal weight” rating on the stock in a research note on Tuesday, November 4th. TD Cowen dropped their target price on Kimberly-Clark from $135.00 to $130.00 and set a “hold” rating on the stock in a research report on Friday, October 31st. BNP Paribas Exane cut their price target on Kimberly-Clark from $127.00 to $110.00 and set a “neutral” rating on the stock in a report on Monday, December 1st. Royal Bank Of Canada reissued an “overweight” rating and issued a $162.00 price target on shares of Kimberly-Clark in a research report on Tuesday, October 28th. Finally, Citigroup dropped their price objective on Kimberly-Clark from $100.00 to $95.00 and set a “sell” rating on the stock in a research report on Wednesday, December 17th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Kimberly-Clark presently has a consensus rating of “Hold” and an average price target of $124.62.

Read Our Latest Research Report on KMB

Kimberly-Clark Company Profile

(Free Report)

Kimberly-Clark Corporation is a U.S.-based multinational manufacturer of personal care and consumer tissue products. The company develops, produces and markets a range of consumer brands and professional products, including facial and bathroom tissues, disposable diapers and training pants, feminine care, incontinence products and workplace hygiene solutions. Known for consumer-facing names such as Kleenex, Huggies, Kotex, Cottonelle and Scott, as well as professional offerings under Kimberly-Clark Professional and KleenGuard, the company supplies goods to retail, healthcare and institutional customers.

Founded in 1872 in Neenah, Wisconsin, Kimberly-Clark has expanded from its 19th-century paper-making roots into a global household and workplace products company.

Recommended Stories

Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMBFree Report).

Institutional Ownership by Quarter for Kimberly-Clark (NASDAQ:KMB)

Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.